Vitamin D Overage: How to Set a Label Claim That Survives Shelf Life

What is vitamin D overage?

A vitamin D3 label promises a number, and that number has to be true on the last day of shelf life, not only on the day the batch is released. Cholecalciferol slowly degrades, so a product that is exactly on target at release can fall below its label claim months later. Vitamin D overage is the extra vitamin D3 added at manufacture to cover that expected loss.

Formulators work between two limits. Too little margin and the product fails its claim at expiry. Too much and the dose drifts upwards for no benefit, raw material is wasted, and a daily-use product can move closer to the tolerable upper intake level. This guide sets out the science and the arithmetic behind a defensible margin for US dietary supplements. It is educational, not regulatory advice.

Why vitamin D3 loses potency in a supplement

Vitamin D3 is a fat-soluble secosteroid that is practically insoluble in water^[8]. It is sensitive to light (photo-oxidation), oxygen, heat (isomerisation) and acidic conditions (acid-catalysed isomerisation)^[1]. These are the drivers of cholecalciferol degradation, and they explain why storage conditions and packaging matter as much as the recipe.

Published figures show how strongly the matrix and the environment change the rate. Fortified wheat flour data, cited in a 2025 review, give a vitamin D3 half-life of about 173 days under dry conditions (water activity 0.33, 25 °C), falling to 116 days at water activity 0.93 and to 63 days at 45 °C^[1]. The same review reports that baking fortified bread at 170 °C retains about 85% of vitamin D, against 40–65% at 200 °C, and that nanoemulsions and mixed micelles kept more than 70% after one month at 4 °C^[1].

None of these numbers can be borrowed for a tablet, softgel or gummy. They show the direction of the effect; your own product’s loss has to be measured on your own format, pack and storage conditions.

How potency loss is modelled: first-order decay and T90

Vitamin loss in a finished product is commonly modelled as first-order decay: the fraction remaining at time t is e^−kt, where the rate constant k rises with temperature and moisture. Shelf life is often described by T₉₀, the time taken for potency to fall to 90% of its initial value.

Formulation changes the answer. In one study, vitamin D3 was formulated as a solid self-microemulsifying system adsorbed on a magnesium aluminometasilicate carrier (Neusilin US2) and compressed into tablets; the tablets met pharmacopeial quality tests and their T₉₀ was reported as 28.12 months^[2]. That is a result for one research formulation, not a benchmark for commercial products.

Release value versus expiry value

Release testing measures the assay value when the batch is made. The label claim must still hold at expiry, so the release specification and the end-of-shelf-life expectation are set as a pair. The difference between them is the loss the formulator has to cover, and it is the basis of every supplement overage calculation.

The stability data an overage calculation needs

Table 1. Methods used to size a vitamin D overage

Content uniformity matters as much as the mean. In a study of directly compressed vitamin D3 tablets with eggshell powder as a filler, vitamin D3 content was 98.77–102.35% of label across formulations, tested against USP weight variation, content uniformity, hardness, friability, disintegration and dissolution^[7].

Under 21 CFR Part 111, manufacturers must establish product specifications for the identity, purity, strength and composition of each finished batch and determine whether those specifications are met^[6]. FDA does not require an expiration date on dietary supplements, but it has stated that any expiration or “best if used by” date placed on a label should be supported by data^[9]. In practice, that means a stability programme. For how accelerated and real-time designs compare, see our guide to real-time and accelerated shelf-life testing.

A worked vitamin D overage calculation

Illustrative example (not client or FRL data). Assume a 24-month shelf life, first-order loss, and stability data showing that the weakest lot retains 90% of its initial vitamin D3 at expiry. The label claim is 50 mcg (2,000 IU) per serving.

• Release potency needed: 100% ÷ 0.90 = 111.1% of label.
• Overage: 111.1% − 100% = 11.1%. The same result written as a formula: (100 − 90) ÷ 90 × 100 = 11.1%.
• Release target: 50 mcg × 1.111 = 55.6 mcg per serving, about 2,222 IU (1 mcg = 40 IU).

This is the minimum. A real specification also has to allow for assay variability and unit-to-unit spread, so the release lower limit usually sits above the calculated target rather than on it. The size of that allowance comes from method validation and uniformity data, not from a rule of thumb.

Checking the result against the upper intake level

The Institute of Medicine set the tolerable upper intake level (UL) for vitamin D at 4,000 IU (100 mcg) a day from age 9, with lower values for younger children: 2,500 IU for ages 1–3 and 3,000 IU for ages 4–8^[5][10]. The UL is a ceiling for total daily intake from all sources, not a target^[10]. In the example, 2,222 IU per serving sits well below the adult UL.

The UL is not a US legal maximum for supplement content, and higher-strength products are sold. But it is the right check for a daily-use product, and the check should use the maximum daily serving and the release upper limit, not the label value. For children’s products, use the age-specific UL. Where a high-dose product approaches its limit, reduce the loss (better pack, better form) rather than adding margin blindly.

What US label rules say about vitamin D overage

Two provisions shape the margin. Vitamin D added to a product is a Class I nutrient, and for Class I nutrients the nutrient content of the composite sample must be formulated to be at least equal to the value declared on the label^[3]. Separately, reasonable excesses of vitamins over labelled amounts are acceptable within current good manufacturing practice^[3][4]. For dietary supplements, 21 CFR 101.36 applies these compliance rules, tested on a composite of 12 consumer packages or 10% of the lot, whichever is smaller^[4].

The amount of vitamin D is declared in mcg; IU may be added voluntarily, in parentheses after the mcg value^[3]. The adult Daily Value used for %DV is 20 mcg^[3]. Reconcile the release target with the Supplement Facts panel before artwork is approved. Our guide to FDA rules for vitamin D supplements covers the label requirements in full.

Table 2. From scientific input to formulation decision

Other markets work differently: the UAE, for example, assesses label claims against a two-sided window. Our UAE supplement label claim and overage guide explains how that changes the calculation.

Common vitamin D overage mistakes to avoid

• Borrowing a half-life from another matrix. Flour, sugar or bread data do not transfer to a tablet, softgel or gummy^[1].
• Trusting an accelerated estimate alone. Accelerated data guide the first margin; real-time data confirm it.
• Sizing from the average lot. Use the lowest retention seen across stability lots, then confirm with real-time assay before release limits are locked.
• Treating label tolerance as two-sided. For added vitamins in the US, the composite must be at least the declared value; reasonable excesses are acceptable within cGMP^[3].
• Treating the UL as a target. It is a ceiling for total daily intake^[10].
• Ignoring the pack. A light and oxygen barrier can reduce the loss that overage has to cover^[1]; see our note on packaging barrier and shelf life.

Formulator’s note. Set the overage from the weakest batch, not the average. Overage is a correction for measured loss, not a substitute for a stable formulation and a protective pack.

Where overage fits in vitamin D3 product development

Overage belongs in a documented specification, not only in a recipe. Part 111 requires specifications and testing to show they are met, and reserve samples must be kept for 1 year past the shelf-life date where shelf-life dating is used, or for 2 years from distribution of the last batch^[6].

The overage decision sits in the middle of the development path. The claims a vitamin D product can make are framed by the clinical evidence, explained in our VITAL trial explainer. Once the margin is set, the vitamin D3 dissolution test walkthrough shows how release is checked on fresh and aged units, and the vitamin D3 supplement case study applies the whole sequence. The same logic applies to other formats: our gummy supplement formulation guide covers overage in a gel matrix.

Conclusion

Vitamin D overage is arithmetic on measured loss: divide the label claim by the fraction retained at expiry, allow for analytical and unit-to-unit variability, then check the release upper limit against the age-appropriate upper intake level. Good formulation reduces the loss first, with a stable form, a protective pack and the right storage conditions, and then sizes the margin from real stability data.

For brands & formulators

Food Research Lab supports US supplement brands from Chennai, India. Our nutraceutical team designs the stability programme, calculates the vitamin D overage from your data and checks the release target against US labelling rules and intake limits. Stability storage, vitamin D3 assay and dissolution testing are run or arranged through accredited partner laboratories.

See our nutraceutical product development service, or our regulatory and scientific research team for label review. You can also contact us with your formula and target shelf life.

In this series

• The VITAL trial explained: what the vitamin D results mean for US supplement makers.
• FDA rules for vitamin D supplements: Supplement Facts, mcg and IU, tolerances and claims.
• Vitamin D overage: setting a label claim that survives shelf life (you are here).
• Vitamin D3 dissolution testing: how release is checked on tablets and softgels.
• Vitamin D3 supplement development: a worked example from formula to label claim.
• Nutraceutical product development: take your vitamin D3 product from brief to launch.

1. Hardinsyah, H., Rahmawati, R., Sulaeman, A., & Nurkolis, F. (2025). A blueprint for vitamin D fortification in sugar: Stability and health impact. Frontiers in Nutrition, 12, 1671785. https://doi.org/10.3389/fnut.2025.1671785 (cited for vitamin D sensitivity to light, oxygen, heat and acid; >90% retention in fortified sugar; flour half-life, bread baking and nanoemulsion retention data)
2. Dangre, P. V., Gurram, N. J., Surana, S. J., & Chalikwar, S. S. (2022). Development and optimization of vitamin D₃ solid self-microemulsifying drug delivery system: Investigation of flowability and shelf life. AAPS PharmSciTech, 23(4), 110. https://doi.org/10.1208/s12249-022-02267-z (cited for tablets on Neusilin US2 meeting pharmacopeial tests and T₉₀ of 28.12 months)
3. U.S. Food and Drug Administration. (2025). 21 CFR 101.9: Nutrition labeling of food (§101.9(c)(8)(iv) vitamin D units and RDI; §101.9(g)(3)–(6) Class I nutrients and reasonable excesses). Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-A/section-101.9
4. U.S. Food and Drug Administration. (2025). 21 CFR 101.36: Nutrition labeling of dietary supplements (§101.36(f)(1) compliance). Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-C/section-101.36
5. Institute of Medicine. (2011). Dietary reference intakes for calcium and vitamin D. National Academies Press. https://doi.org/10.17226/13050 (cited for the vitamin D tolerable upper intake levels)
6. U.S. Food and Drug Administration. (2025). 21 CFR Part 111: Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements (§111.70 specifications; §111.75 testing; §111.83 reserve samples). Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
7. Haq, N., Ibrahim, M. A., Alsarra, I. A., Alshehri, S., Alam, P., & Shakeel, F. (2024). Utilization of waste eggshell powder as an excipient for vitamin D3 tablet preparation. ACS Omega, 9(3), 3980–3987. https://doi.org/10.1021/acsomega.3c08416 (cited for vitamin D3 content of 98.77–102.35% and the USP test battery)
8. Wang, F., Yu, W., Popescu, C., Ibrahim, A. A., Yu, D., Pearson, R., MacKerell, A. D., Jr., & Hoag, S. W. (2022). Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation. Pharmaceutical Development and Technology, 27(4), 389–398. https://doi.org/10.1080/10837450.2022.2064492 (cited for vitamin D3 being practically insoluble in water)
9. U.S. Food and Drug Administration. (2007). Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; Final rule. Federal Register, 72(121), 34752–34958 (expiration dating discussed at 34855–34856). https://www.govinfo.gov/content/pkg/FR-2007-06-25/pdf/07-3039.pdf (cited for: expiration dating not required; any date on a label should be supported by data)
10. Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., Kovacs, C. S., Mayne, S. T., Rosen, C. J., & Shapses, S. A. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. Journal of Clinical Endocrinology & Metabolism, 96(1), 53–58. https://doi.org/10.1210/jc.2010-2704 (cited for ULs by age and the UL as a ceiling, not a target)